ElThe géneroenus Malachra L. pbertenece a lalongs to the familiay Malvaceae. Incluye hierbas o subarbustos de nueve et includes herbs or subshrubs of nine accepted species aceptadas con awith approximadamente treinta sinónimos, y ha sido ampliamente utilizado en la medicina popular comunitaria para tratarately thirty synonyms, and it has been widely used in community folk medicine to treat health problemas de salud que incluyens including inflamación, mmation, nasal obstrucción nasaltion, leishmaniasis, malaria, parto, trastornos renales, fiebre, enfermedades del tractochildbirth, kidney disorders, fever, respiratorio, entre otros. otroy tract diseases, among others.
Malachra species | Plant Part Used | Phytoconstituents | Reference |
---|---|---|---|
Malachra alceifolia Jacq. | Leaf | Flavonoids, steroids, triterpenes |
Malachra Species | Plant Part Used | Extract/Compounds | Pharmacological Activity | Concentration | Method | Major Findings | Reference | ||
---|---|---|---|---|---|---|---|---|---|
anthocyanins, leucoanthocyanins, saponins | [ | 22 | ] | ||||||
Flowers | |||||||||
M. alceifolia Jacq. | Leaf | Ethanolic | Antiplasmodial | 10 µg/mL | In vitro Plasmodium falciparum 152.2 ± 28.6 nMIn vitro Plasmodium falciparum Chloroquine152.2 ± 28.6 controlnM Chloroquine control |
Inhibitory activity on P. falciparum ferriprotoporphyrin biomineralization inhibition |
[31,32 | ||
Flavonoids, steroids, triterpenes | anthocyanins, leucoanthocyanins |
||||||||
Malachra capitata (L.) L. | Root | Gallic acid (1), caffeic acid (2), rutin (3), quercetin (4), ferulic acid (5) | [23,24] | ||||||
Leaf | Rutin, ferulic acid | ||||||||
] | Stem | Gallic acid | |||||||
Whole plant | β-Sitosterol (6) | [25] | |||||||
Root | Carbohydrates, phenols, flavonoids, glycosides, triterpenes, alkaloids, tannins, saponins | [23,24] | |||||||
Root | Tetradecanoic acid, ethyl ester (7); | [23,24] | |||||||
linolenic acid, ethyl ester (8); | |||||||||
(E)-11-hexadecenoic acid, ethyl ester (9); | |||||||||
hexadecanoic acid, ethyl ester (10); | |||||||||
a | A | nti | microbianobacterial | 80 microµgramos | CIM in vitroIn vitro MIC |
Inhibictión del crecimiento don of the P. aeruginosa, B. subtilis, C. albicans ,growth of P. aeruginosa, B. subtilis, C. albicans |
[ 29 ] | octadecanoic acid, ethyl ester (11); | |
HojLeaf | DescUnknownocido | FPhototóoxico (fotosensibilización) (photosensitization) |
DescUnknownocido | Ovejas hembras y machos in vivoIn vivo sheep females and male |
Causa de fotodermatitisof primaria en ovejas por ingestión de hojay photodermatitis in sheep ingestion leaf |
[ 77 ] | didecyl phthalate (12); | ||
HojLea | ( | ||||||||
Shoot | Ethanolic | Antiplasmodial | 77 µg/mL | In vitro Plasmodium falciparum (3D7) chloroquineIn vitro Plasmodium falciparum (concentration no report3D7) chloroquine (concentration no report) |
Inhibitory activity on P. falciparum |
[33] | |||
M. capitata (L.) L. |
Leaf | Ethanolic | Antibacterial | 62.5 ppm | In vitro MIC |
Inhibition of the growth of Propionibacterium acnes (ATCC 6919) |
[71] | ||
Shoot | Aqueous | Antidiarrhoeal | 200 and 400 mg/kg | In vivo oral administration toIn vivo Wistar rats; castor oil-induced diarrhoea, enteropooling, and small intestinal transit; 5 mL/kg, p.o diphenoxlate contral administration tol Wistar rats; castor oil-induced diarrhoea, enteropooling, and small intestinal transit; 5 mL/kg, p.o diphenoxlate control |
Decreases intestinal transit | [72] | |||
Aqueous | Anti-epileptic | 250 and 500 mg/kg | In vivo maximal electroshock (MES) and pentylenetetrazole (PTZ)-induced seizuresmodels in albino Wistar rats,In vivo maximal electroshock (MES) and pentylenetetrazol controle (PTZ)-induced seizuresmodels in albino Wistar rats, pentylenetetrazol control |
Anticonvulsant activity against MES and PTZ animal models | [72] | ||||
Aqueous | Anti-ulcerogenic | 200 mg/kg y 400 mg/kg | Administración oral in vivo a ratas Wistar modelo con ligadura de píloro, 50 mg/kg, control de po ranitidinaIn vivo oral administration to Wistar rats pylorus ligated model, 50mg/kg, p.o ranitidine control |
Reducir la secreción de ácido gá the gastrico del píloro. acid secretion of pylorus |
[ 72 ] | ||||
Acquoeouso | aAntioxidante | 200 y 400 mg/kg | Administración oral in vivo a ratas WistarIn vivo oral administration to Wistar rats |
Inhibir la acumulación de productos de peroxidación lipídica, actividades de superóxido dismutasa y catalasaIn vivo oral administration to Wistar rats pylorus ligated model, 50mg/kg, p.o ranitidine control |
[ 73 ] | ||||
Acquoeouso | hepatoprotectorHepatoprotective | 100, 200 y 400 mg/kg | Administración oral in vivo a ratas Wistar, hepatotoxicidad inducida por tetracloruro de carbono CCl In vivo4 oral administration to Wistar rats, carbon tetrachloride CCl4 induced hepatotoxicity |
NivelRes reducidos de las enzimas hepáticas SGOT, SGPT, fosfatasa alcalina (ALP) y duced levels of the fosfhepatasa ácida (ACP)ic enzymes SGOT, SGPT, alkaline phosphatase (ALP), and acid phosphatase (ACP) |
[ 74 ] | ||||
Nanopartículas dLe hoja de plata (AgNP)af silver nanoparticles (AgNPs) |
n-hexanoe | aAntibacterianol | 1 mmM | CIM in vitroIn vitro MIC |
Nanopartíiculas bactericidales Bacillus subtillis , Micrococcus Luteus, Staphylococcus aureus y Pseudomonas aeruginosabactericidal Bacillus subtillis, Micrococcus Luteus, Staphylococcus aureus and Pseudomonas aeruginosa |
[ 75 ] | |||
HojLeaf | mMetanólicohanolic, cloroformo benceno Chloroform Benzene |
aAntibacterianol | 50 mg/mlL | CIM in vitroIn vitro MIC |
Inhibictión del crecimiento don of the Escherichia coli Listeria monocytogenesgrowth of Escherichia coli, Listeria monocytogenes |
[ 76 ] | |||
Malachra fasciata Jacq. | HojLeaf | Chloroformo/ Acetato de aurantiamidae acetate f |
Chloroformo | Antifúungicoal | 30 µg | CIM in vitroIn vitro MIC |
Inhibictión del crecimiento don of the Z,Z,Z)-1,4,6,9-nonadecatetraene (13); | ||
Aspergillus niger | growth of | Aspergillus niger | [ | 29 ] | squalene | ||||
HojLeaf | -(-)loliolida(14) | ||||||||
e | Antimutag | éenico | 8 mg/kg | Prueba de micronúcleos in vitro inducida con mitomicina C, 32%In vitro micronucleus test induced using mitomycin C, 32% |
Reducire el númthe numbero de eritrocitos policromáticos micronucleados (MPCE) of micronucleated polychromatic erythrocytes (MPCE) |
[ 30 ] | Stem | Tetradecanoic acid, ethyl ester; | [27,28] |
pentadecanoic acid, 2,6,10,14- tetramethyl methyl ester (15); |
|||||||||
linolenic acid, methyl ester; | |||||||||
(E)-11-hexadecenoic acid, ethyl ester; | |||||||||
octadecanoic acid, ethyl ester; | |||||||||
(Z,Z,Z)-1,4,6,9-nonadecatetraene | |||||||||
azobenzene, 4,4′-dibromo- (16); | |||||||||
squalene | |||||||||
oleic acid (17) | |||||||||
Cholestan-3-ol, 2-methylene-(3β,5α)- (18); | |||||||||
Leaf | Tetradecanoic acid, ethyl ester | [27,28] | |||||||
3,7,11,15-tetramethyl-2-hexadecen-1-ol (19); | |||||||||
Oxirane, tetradecyl- (20); | |||||||||
(E)-11-hexadecenoic acid, ethyl ester | |||||||||
Hexadecanoic acid, ethyl ester | |||||||||
Phytol (21); | |||||||||
(Z,Z) 6,9 pentadecadien-1-ol (22); | |||||||||
(Z,Z) 9,12-octadecadienoic acid (23); | |||||||||
octadecanoic acid, ethyl ester; | |||||||||
squalene | |||||||||
Leaf | Flavonoids, glycosides, triterpenes, alkaloids, tannins, saponins, phlobatannins | [27,28] | |||||||
Malachra fasciata Jacq. | Leaf | Aurantiamide acetate (24) | [29] | ||||||
Leaf | 1,3-Diacylglycerol (25) 1,2-Diacylglycerol (26) |
[30] |